Skip to main content
Erschienen in: European Radiology 4/2013

01.04.2013 | Nuclear Medicine

Variability of 18F-FDG-positive lung lesion volume by thresholding

verfasst von: Eric Laffon, Henri de Clermont, Roger Marthan

Erschienen in: European Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess the variability of 18F-FDG-positive volume measurements in lung cancer patients, obtained with different fixed percentages of maximum standard uptake value (SUVmax) thresholds.

Methods

PET dynamic acquisition involving ten frames was performed within 60–110 min post-injection in eight patients. In each lesion (n = 11), volume was automatically outlined in each frame with fixed 40–50–60–70 % of the SUVmax thresholds. Thus, ten volume values for each threshold (V40–50–60–70) were available to calculate relative SD (SDr), and hence relative measurement error (MEr) and repeatability (R). Dependence on SUVmax variability was also assessed.

Results

Mean SDr (<SDr>; %) of volume estimates was found to strongly correlate with threshold value (T; %): <SDr> = 1.626 × exp(0.044 × T) (r = 0.999; P < 0.01). MEr and R for V40 were found to be (95 % CL) 18.9 % and 26.7 %. For all fixed thresholds, in successive frames of an arbitrary lesion, volume estimate inversely correlated with SUVmax (P ≤ 0.02).

Conclusions

A formula allows estimation of the variability of 18F-FDG-positive volumes provided by any fixed percentage of SUVmax threshold, and hence by any thresholding method. It only necessitates conversion of the threshold value into the SUVmax percentage in order to aid quick estimation of volume variability magnitude in current clinical practice.

Key Points

In oncology, PET is widely used to assess the metabolic active volume
This paper investigates the variability of 18 F-FDG-positive volumes by thresholding
A formula is available for estimating this variability for any thresholding method
For 40 %-SUVmax threshold, measurement error and repeatability are (95 % CL) 18.9 %/26.7 %
Literatur
1.
Zurück zum Zitat Zasadny KR, Kison PV, Francis IR, Wahl RL (1998) FDG-PET determination of metabolically active tumor volume and comparison with CT. Clin Positron Imaging 1:123–129PubMedCrossRef Zasadny KR, Kison PV, Francis IR, Wahl RL (1998) FDG-PET determination of metabolically active tumor volume and comparison with CT. Clin Positron Imaging 1:123–129PubMedCrossRef
2.
Zurück zum Zitat Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, Humm JL (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505–2509PubMedCrossRef Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, Humm JL (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505–2509PubMedCrossRef
3.
Zurück zum Zitat Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A (2007) Segmentation of PET volumes by iterative image thresholding. J Nucl Med 48:108–114PubMed Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A (2007) Segmentation of PET volumes by iterative image thresholding. J Nucl Med 48:108–114PubMed
4.
Zurück zum Zitat Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Grégoire V (2003) Tridimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of the reconstruction algorithms. Radiother Oncol 69:247–250PubMedCrossRef Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Grégoire V (2003) Tridimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of the reconstruction algorithms. Radiother Oncol 69:247–250PubMedCrossRef
5.
Zurück zum Zitat Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D (2004) Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 690:1272–1282CrossRef Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D (2004) Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 690:1272–1282CrossRef
6.
Zurück zum Zitat Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C, Lirsch CM (2007) Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:453–462PubMedCrossRef Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C, Lirsch CM (2007) Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:453–462PubMedCrossRef
7.
Zurück zum Zitat Visser EP, Boerman OC, Oyen WJG (2010) SUV: from silly useless value to smart uptake value. J Nucl Med 51:173–175PubMedCrossRef Visser EP, Boerman OC, Oyen WJG (2010) SUV: from silly useless value to smart uptake value. J Nucl Med 51:173–175PubMedCrossRef
9.
Zurück zum Zitat Bland JM, Altman DG (1996) Statistics notes: Measurement error proportional to the mean. BMJ 313:106–108PubMedCrossRef Bland JM, Altman DG (1996) Statistics notes: Measurement error proportional to the mean. BMJ 313:106–108PubMedCrossRef
10.
Zurück zum Zitat De Ruysscher D, Nestle U, Jeraj R, MacManus M (2012) PET scans in radiotherapy planning of lung cancer. Lung Cancer 75:141–145PubMedCrossRef De Ruysscher D, Nestle U, Jeraj R, MacManus M (2012) PET scans in radiotherapy planning of lung cancer. Lung Cancer 75:141–145PubMedCrossRef
11.
Zurück zum Zitat Feng M, Kong F-M, Gross M, Fernando S, Hayman JA, Ten Haken RK (2009) Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73:1228–1234PubMedCrossRef Feng M, Kong F-M, Gross M, Fernando S, Hayman JA, Ten Haken RK (2009) Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73:1228–1234PubMedCrossRef
12.
Zurück zum Zitat Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P (2011) Serial assessment of FDG-PET uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC). Radiother Oncol 102:251–257PubMedCrossRef Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P (2011) Serial assessment of FDG-PET uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC). Radiother Oncol 102:251–257PubMedCrossRef
13.
Zurück zum Zitat Tylski P, Stute S, Grotus N, Doyeux K, Hapdey S, Gardin I, Vanderlinden B, Buvat I (2010) Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET. J Nucl Med 51:268–276PubMedCrossRef Tylski P, Stute S, Grotus N, Doyeux K, Hapdey S, Gardin I, Vanderlinden B, Buvat I (2010) Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET. J Nucl Med 51:268–276PubMedCrossRef
14.
Zurück zum Zitat Frings V, de Langen AJ, Smit EF, van Helden FH, Hoekstra OS, van Tinteren H, Boellaard (2010) Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med 51:1870–1877PubMedCrossRef Frings V, de Langen AJ, Smit EF, van Helden FH, Hoekstra OS, van Tinteren H, Boellaard (2010) Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med 51:1870–1877PubMedCrossRef
15.
Zurück zum Zitat Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945PubMedCrossRef Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945PubMedCrossRef
16.
Zurück zum Zitat de Langen AJ, Vincent A, Velasquez LM, van Tinteren H, Boellaard R, Shankar LK, Boers M, Smit EF, Stroobants S, Weber WA, Hoekstra OS (2012) Repeatability of 18F-FDG uptake measurements in tumours: a meta-analysis. J Nucl Med 53:701–708PubMedCrossRef de Langen AJ, Vincent A, Velasquez LM, van Tinteren H, Boellaard R, Shankar LK, Boers M, Smit EF, Stroobants S, Weber WA, Hoekstra OS (2012) Repeatability of 18F-FDG uptake measurements in tumours: a meta-analysis. J Nucl Med 53:701–708PubMedCrossRef
17.
Zurück zum Zitat Boellaard R (2011) Need for standardization of 18F-FDG PET/CT for treatment response assessments. J Nucl Med 52:93S–100SPubMedCrossRef Boellaard R (2011) Need for standardization of 18F-FDG PET/CT for treatment response assessments. J Nucl Med 52:93S–100SPubMedCrossRef
18.
Zurück zum Zitat Laffon E, de Clermont H, Marthan R (2011) A method of adjusting SUV for injection-acquisition time differences in 18F-FDG PET imaging. Eur Radiol 21:2417–2424PubMedCrossRef Laffon E, de Clermont H, Marthan R (2011) A method of adjusting SUV for injection-acquisition time differences in 18F-FDG PET imaging. Eur Radiol 21:2417–2424PubMedCrossRef
19.
Zurück zum Zitat Nakamoto Y, Zadsadny KR, Minn H, Wahl R (2002) Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-Deoxy-2-[18F]Fluoro-D-Glucose. Molecular Imaging and Biology 4:171–178PubMedCrossRef Nakamoto Y, Zadsadny KR, Minn H, Wahl R (2002) Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-Deoxy-2-[18F]Fluoro-D-Glucose. Molecular Imaging and Biology 4:171–178PubMedCrossRef
20.
Zurück zum Zitat Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thor Oncol 2:706–714CrossRef Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thor Oncol 2:706–714CrossRef
21.
Zurück zum Zitat Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, Cosset JM, Housset M, Touboul E (2000) Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48:1015–1024PubMedCrossRef Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, Cosset JM, Housset M, Touboul E (2000) Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48:1015–1024PubMedCrossRef
Metadaten
Titel
Variability of 18F-FDG-positive lung lesion volume by thresholding
verfasst von
Eric Laffon
Henri de Clermont
Roger Marthan
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 4/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2672-2

Weitere Artikel der Ausgabe 4/2013

European Radiology 4/2013 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.